This Amedeo Smart survey is supported by AngelsInitiative.com.
AmedeoSepsis |
|
Free Subscription
AIDS |
- September 2025
- NAVARRO-SOLER R, Martin-Torres J, Lagarde M, Bisbal O, et al
Impact of antiretroviral regimens containing Integrase Inhibitors on achieving viral suppression at ultra-low levels compared to other ART strategies.
AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004340.
>> Share
July 2025 - SUZUKI K, Levert A, Yoo E, Cysique LA, et al
Higher levels of cell-associated HIV-1 RNA transcripts predict risk of viral blips: implications for clinical management and cure research.
AIDS. 2025;39:1300-1302.
>> Share
June 2025 - BERNAL E, Martinez-Rodriguez R, Gomez JM, Tomas C, et al
Low-level viremia linked to virological failure but not clinical events: a competing risks study.
AIDS. 2025 Jun 3. doi: 10.1097/QAD.0000000000004248.
>> Share
August 2024 - NEARY J, Chebet D, Benki-Nugent S, Moraa H, et al
Association between HIV and cytomegalovirus and neurocognitive outcomes among children with HIV.
AIDS. 2024 Aug 29. doi: 10.1097/QAD.0000000000004000.
>> Share
- ALDREDGE A, Mehta CC, Lahiri CD, Schneider MF, et al
Consequences of low-level viremia among women with HIV in the United States from 2003 - 2020.
AIDS. 2024 Aug 7. doi: 10.1097/QAD.0000000000003990.
>> Share
July 2024 - MANN SC, Tong W, Abraham AG, Palella F, et al
The impact of diabetes mellitus on HIV virologic control: results of the MACS/WIHS combined cohort study.
AIDS. 2024 Jul 19. doi: 10.1097/QAD.0000000000003978.
>> Share
June 2024 - SODEKE O, Milligan K, Ezeuko I, Oladipo A, et al
Longitudinal viral load outcomes of adults with HIV after detectable viremia on tenofovir, lamivudine, and dolutegravir.
AIDS. 2024 Jun 13. doi: 10.1097/QAD.0000000000003956.
>> Share
May 2024 - WASILWA A, Amadi E, Ramadhani HO, Lascko T, et al
Impact of enhanced adherence counselling on viral re-suppression among adolescents and young persons with persistent viremia.
AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003945.
>> Share
January 2024 - DUNCAN MC, Omondi FH, Kinloch NN, Lapointe HR, et al
Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size.
AIDS. 2024 Jan 15. doi: 10.1097/QAD.0000000000003841.
>> Share
December 2023 - DORWARD J, Govender K, Moodley P, Lessells R, et al
Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir based antiretroviral therapy.
AIDS. 2023 Dec 19. doi: 10.1097/QAD.0000000000003818.
>> Share
October 2023 - LARTEY M, Ganu VJ, Tachi K, Yang H, et al
Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and HBV viral suppression.
AIDS. 2023 Oct 20. doi: 10.1097/QAD.0000000000003764.
>> Share
September 2023 - RACCAGNI AR, Diotallevi S, Lolatto R, Lucente MF, et al
Viral blips and virologic failures following mpox vaccination with MVA-BN among people with HIV.
AIDS. 2023 Sep 29. doi: 10.1097/QAD.0000000000003733.
>> Share
July 2023 - CHUN HM, Milligan K, Boyd MA, Abutu A, et al
Reaching HIV epidemic control in Nigeria using a lower HIV viral load suppression cut-off.
AIDS. 2023 Jul 28. doi: 10.1097/QAD.0000000000003672.
>> Share
June 2023 - LEES EA, Tickner N, Lyall H, Mcmaster P, et al
Infant postnatal prophylaxis following maternal viraemia during breastfeeding.
AIDS. 2023;37:1185-1186.
>> Share
February 2023 - CHAISSON LH, Semitala FC, Nangobi F, Steinmetz S, et al
Viral suppression among adults with HIV receiving routine dolutegravir-based antiretroviral therapy and 3HP.
AIDS. 2023 Feb 8. doi: 10.1097/QAD.0000000000003508.
>> Share
January 2023 - BOWMAN C, Ambrose A, Kanitkar T, Flores K, et al
Real world use of dolutegravir two drug regimens.
AIDS. 2023 Jan 16. doi: 10.1097/QAD.0000000000003480.
>> Share
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016
